Those Involved in Compound Pharmaceuticals Beware: Law Enforcement Is Focused on You

Update Magazine | November/December 2017

Those Involved in Compound Pharmaceuticals Beware: Law Enforcement Is Focused on You2018-06-26T13:16:43-04:00

The Dietary Supplement Industry in the Time of Trump: Potential Opportunities and Pitfalls

Update Magazine | September/October 2017

The Dietary Supplement Industry in the Time of Trump: Potential Opportunities and Pitfalls2018-06-26T13:16:44-04:00

Compounding the Off-Label Promotion Debate: How FDA Could Regulate the Promotion of Unapproved Drugs

Update Magazine | September/October 2017

Compounding the Off-Label Promotion Debate: How FDA Could Regulate the Promotion of Unapproved Drugs2017-11-16T13:49:29-05:00

Intellectual Property for the Food and Drug Law Professional: Issues that Arise in the Product Development Process

Update Magazine | September/October 2017

Intellectual Property for the Food and Drug Law Professional: Issues that Arise in the Product Development Process2017-11-16T13:49:39-05:00

The “New” NDC: Are You Aware of FDA’s Rollout of the New Unique Medical Device Identifier (UDI) and Its Potential Future Impact on Payer Claims Forms?

Update Magazine | September/October 2017

The “New” NDC: Are You Aware of FDA’s Rollout of the New Unique Medical Device Identifier (UDI) and Its Potential Future Impact on Payer Claims Forms?2017-11-16T13:49:48-05:00

Regulatory Update on Acrylamide—State, Federal, and International Oversight

Update Magazine | September/October 2017

Regulatory Update on Acrylamide—State, Federal, and International Oversight2017-11-16T13:53:34-05:00
Go to Top